Beyond Meat Delays Q3 2025 Results as Company Prepares Major Impairment Charge
Date: 2025-11-04
Beyond Meat postponed the release of its third quarter 2025 results to Tuesday, November 11, after market close. The decision gives the company more time to complete an assessment of a material non-cash impairment charge tied to long-lived assets for the period ending September 27, 2025. The exact value of the charge remains under review.
This update follows a Form 8-K filing from October 24, where Beyond Meat first indicated an impairment was coming. The earnings call will take place the same day at 5:00 p.m. Eastern time. A webcast will stream on the company’s investor portal with an archive posted afterward.
Founded in 2009, Beyond Meat produces plant-based meat alternatives without GMOs, added hormones, antibiotics, or cholesterol. Its products replicate the texture and flavor profile of traditional animal meat and are sold through retail and foodservice channels.
The delay arrives during a period of financial restructuring and shifting demand trends. Beyond Meat recently completed an exchange offer for its 0% Convertible Senior Notes due 2027. Roughly 97.16% of the notes were tendered, equal to about $1.12 billion. Final settlement is expected on October 30. The exchange reduces total debt from about $1.15 billion to roughly $250 million, lowering future interest obligations and extending liquidity runway.
Preliminary third quarter net sales stand near $70 million, in line with guidance between $68 million and $73 million. This figure reflects a 14 percent year-over-year decline. Expected gross margin sits between 10 percent and 11 percent, pressured in part by costs tied to China operations. Analysts from Mizuho reaffirmed an Underperform rating with a $1.50 price target, pointing to equity dilution linked to the debt exchange.
Beyond Meat also introduced new clean label Beyond Burger and Beyond Beef products at Erewhon stores. Each serving delivers 21 grams of protein with no GMOs or added hormones and uses a simplified ingredient list. The launch signals ongoing product development while the business resets its financial structure and navigates shifting retail demand patterns.
Investors will watch next week’s report for clarity on impairment size, margin direction, and updated cost controls. The earnings call will offer guidance on international performance and rollout plans for recent product innovations, setting expectations for the remainder of the fiscal year.
